Anonymous ID: b722c1 Aug. 29, 2021, 3:36 a.m. No.14484930   🗄️.is 🔗kun

There were at least 15 million ballots that were mailed out and were unaccounted for.

 

What might have happened in some cases:

  1. Mail a ballot to everyone

  2. Many ballots get returned to sender

  3. Return to sender ballots end up in anonymous drop boxes

 

https://t.me/CodeMonkeyZ/1350

 

https://www.breitbart.com/politics/2021/08/28/j-christian-adams-15-million-mail-ballots-unaccounted-for-2020-election/

Anonymous ID: b722c1 Aug. 29, 2021, 3:40 a.m. No.14484941   🗄️.is 🔗kun   >>4955 >>4966 >>4993

>>14484925

This site will go down in history as a part of a plan to destroy the evil.

 

I can bet every word written here will be studied…

 

There will be people who will dedicate their life to research this board.

 

Funny thing is, they still dont know about Q or think its a consp theory.

Anonymous ID: b722c1 Aug. 29, 2021, 4:26 a.m. No.14485040   🗄️.is 🔗kun

Live coverage on Ida storm.

 

Now, take a peek on comments..many are that trump won and biden is a disaster haha

 

America i awake guys. Its a random channel.

Anonymous ID: b722c1 Aug. 29, 2021, 5:39 a.m. No.14485252   🗄️.is 🔗kun   >>5330 >>5412

Go to Tineye and search pics that mcafee is droping.

 

For example..

 

The pic of an asian girl taped is 6 years old. First date goes back to 2015.

 

Does mcafee really have something?

I mean, does that tg acc have something?

 

All we see are images from around the internet.

 

He s been threatning alot.

I mean, that tg acc..

 

Plus, doing weird things with Q drops and it looks like someone writing that(mcafee acc) looks totally idiotic.

Anonymous ID: b722c1 Aug. 29, 2021, 5:41 a.m. No.14485258   🗄️.is 🔗kun

BOOM: “On A Scale of 1 to 10… I Would Say It’s a 12!” – Jovan Pulitzer On the Seriousness of the Audit Results in His 197 Pages in Arizona Audit Report

 

Jovan Pulitzer released another audio today that explains the audit process from this past week forward in Arizona.  Pulitzer recommends that the entire election system should be redone.  The results of the Arizona audit are going to be shocking.  

 

We’re in this crisis today because our paper, our ballets, got mucked up.  So the two things that built our country are back in play today – the paper – that Declaration of Independence built our country – in combination with two, passionate patriots.  And there are only two things that will save our country, that is auditing the paper or ballots and passionate patriots…

 

… Arizona audit was the fastest, most efficient and most cost-effective, for the number of ballots it audited ever, in the history of the world much less the United States…

 

…The Democrats forbid [Democrat] participation and then started releasing propaganda that it was only a conservative effort…

 

…What’s going on here is all these people participated.  There is a tremendous amount of people that had to be hired, there was a tremendous amount of volunteers.  So now you have all these experts from all around the country and everybody is putting together their reports.  Right, so that’s at the top of the pyrimid.  I’m putting together my report.  Other people are putting together their report.  Paper examiners are putting together their reports.  Cyber guys are putting together their reports.  Everybody is putting together their reports.

 

Now these reports go into one central person location and they are put into one all inclusive initial report…

 

https://www.thegatewaypundit.com/2021/08/boom-scale-1-10-say-12-jovan-pulitzer-seriousness-audit-results-197-pages-arizona-audit-report/

Anonymous ID: b722c1 Aug. 29, 2021, 6:07 a.m. No.14485337   🗄️.is 🔗kun   >>5683

Ivermectin helps. its a fact

 

 

Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials.

 

 

Data sources:

 

We searched bibliographic databases up to April 25, 2021. Two review authors sifted for studies, extracted data, and assessed risk of bias. Meta-analyses were conducted and certainty of the evidence was assessed using the GRADE approach and additionally in trial sequential analyses for mortality. Twenty-four randomized controlled trials involving 3406 participants met review inclusion.

 

Therapeutic Advances:

 

Meta-analysis of 15 trials found that ivermectin reduced risk of death compared with no ivermectin (average risk ratio 0.38, 95% confidence interval 0.19–0.73; n = 2438; I2 = 49%; moderate-certainty evidence). This result was confirmed in a trial sequential analysis using the same DerSimonian–Laird method that underpinned the unadjusted analysis. This was also robust against a trial sequential analysis using the Biggerstaff–Tweedie method. Low-certainty evidence found that ivermectin prophylaxis reduced COVID-19 infection by an average 86% (95% confidence interval 79%–91%). Secondary outcomes provided less certain evidence. Low-certainty evidence suggested that there may be no benefit with ivermectin for “need for mechanical ventilation,” whereas effect estimates for “improvement” and “deterioration” clearly favored ivermectin use. Severe adverse events were rare among treatment trials and evidence of no difference was assessed as low certainty. Evidence on other secondary outcomes was very low certainty.

 

Conclusions:

 

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

 

Keywords: ivermectin, prophylaxis, treatment, COVID-19, SARS-CoV-2

 

INTRODUCTION

 

To date, very few treatments have been demonstrated to reduce the burden of morbidity and mortality from COVID-19. Although corticosteroids have been proven to reduce mortality in severe disease,1 there has been little convincing evidence on interventions that may prevent disease, reduce hospitalizations, and reduce the numbers of people progressing to critical disease and death.

 

Ivermectin is a well-known medicine that is approved as an antiparasitic by the World Health Organization and the US Food and Drug Administration. It is widely used in low- and middle-income countries (LMICs) to treat worm infections.2,3 Also used for the treatment of scabies and lice, it is one of the World Health Organization’s Essential Medicines.4 With total doses of ivermectin distributed apparently equaling one-third of the present world population,5 ivermectin at the usual doses (0.2–0.4 mg/kg) is considered extremely safe for use in humans.6,7 In addition to its antiparasitic activity, it has been noted to have antiviral and anti-inflammatory properties, leading to an increasing list of therapeutic indications.8

 

Since the start of the SARS-CoV-2 pandemic, both observational and randomized studies have evaluated ivermectin as a treatment for, and as prophylaxis against, COVID-19 infection. A review by the Front Line COVID-19 Critical Care Alliance summarized findings from 27 studies on the effects of ivermectin for the prevention and treatment of COVID-19 infection, concluding that ivermectin “demonstrates a strong signal of therapeutic efficacy” against COVID-19.9 Another recent review found that ivermectin reduced deaths by 75%.10 Despite these findings, the National Institutes of Health in the United States recently stated that “there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19,”11 and the World Health Organization recommends against its use outside of clinical trials.12

 

 

Currently, ivermectin is commercially available and affordable in many countries globally.6 A 2018 application for ivermectin use for scabies gives a direct cost of $2.90 for 100 12-mg tablets.22 A recent estimate from Bangladesh23 reports a cost of US$0.60—US$1.80 for a 5-day course of ivermectin. For these reasons, the exploration of ivermectin's potential effectiveness against SARS-CoV-2 may be of particular importance for settings with limited resources.24 If demonstrated to be effective as a treatment for COVID-19, the cost-effectiveness of ivermectin should be considered against existing treatments and prophylaxes.

 

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248252/